These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9654064)

  • 41. Acute phase protein alpha 1-acid glycoprotein interacts with plasminogen activator inhibitor type 1 and stabilizes its inhibitory activity.
    Boncela J; Papiewska I; Fijalkowska I; Walkowiak B; Cierniewski CS
    J Biol Chem; 2001 Sep; 276(38):35305-11. PubMed ID: 11418606
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Determination of the vitronectin binding site on plasminogen activator inhibitor 1 (PAI-1).
    van Meijer M; Gebbink RK; Preissner KT; Pannekoek H
    FEBS Lett; 1994 Oct; 352(3):342-6. PubMed ID: 7523190
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human endothelial cells grow poorly on vitronectin: role of PAI-1.
    Underwood PA; Bean PA; Cubeddu L
    J Cell Biochem; 2001 Apr 2-27; 82(1):98-109. PubMed ID: 11400167
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Localization of vitronectin binding domain in plasminogen activator inhibitor-1.
    Lawrence DA; Berkenpas MB; Palaniappan S; Ginsburg D
    J Biol Chem; 1994 May; 269(21):15223-8. PubMed ID: 7515053
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Construction of a plasminogen activator inhibitor-1 variant without measurable affinity to vitronectin but otherwise normal.
    Jensen JK; Durand MK; Skeldal S; Dupont DM; Bødker JS; Wind T; Andreasen PA
    FEBS Lett; 2004 Jan; 556(1-3):175-9. PubMed ID: 14706846
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.
    Waltz DA; Natkin LR; Fujita RM; Wei Y; Chapman HA
    J Clin Invest; 1997 Jul; 100(1):58-67. PubMed ID: 9202057
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vimentin exposed on activated platelets and platelet microparticles localizes vitronectin and plasminogen activator inhibitor complexes on their surface.
    Podor TJ; Singh D; Chindemi P; Foulon DM; McKelvie R; Weitz JI; Austin R; Boudreau G; Davies R
    J Biol Chem; 2002 Mar; 277(9):7529-39. PubMed ID: 11744725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. uPA binding to PAI-1 induces corneal myofibroblast differentiation on vitronectin.
    Wang L; Ly CM; Ko CY; Meyers EE; Lawrence DA; Bernstein AM
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4765-75. PubMed ID: 22700714
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of cell adhesion by PAI-1.
    Loskutoff DJ; Curriden SA; Hu G; Deng G
    APMIS; 1999 Jan; 107(1):54-61. PubMed ID: 10190280
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reversible cellular adhesion to vitronectin linked to urokinase receptor occupancy.
    Waltz DA; Chapman HA
    J Biol Chem; 1994 May; 269(20):14746-50. PubMed ID: 7514182
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time-resolved polarized fluorescence spectroscopy studies of plasminogen activator inhibitor type 1: conformational changes of the reactive center upon interactions with target proteases, vitronectin and heparin.
    Fa M; Karolin J; Aleshkov S; Strandberg L; Johansson LB; Ny T
    Biochemistry; 1995 Oct; 34(42):13833-40. PubMed ID: 7577977
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metals affect the structure and activity of human plasminogen activator inhibitor-1. I. Modulation of stability and protease inhibition.
    Thompson LC; Goswami S; Ginsberg DS; Day DE; Verhamme IM; Peterson CB
    Protein Sci; 2011 Feb; 20(2):353-65. PubMed ID: 21280127
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis.
    Leik CE; Su EJ; Nambi P; Crandall DL; Lawrence DA
    J Thromb Haemost; 2006 Dec; 4(12):2710-5. PubMed ID: 17010152
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A steady-state competition model describes the modulating effects of thrombomodulin on thrombin inhibition by plasminogen activator inhibitor-1 in the absence and presence of vitronectin.
    Dekker RJ; Pannekoek H; Horrevoets AJ
    Eur J Biochem; 2003 May; 270(9):1942-51. PubMed ID: 12709053
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Urokinase-type plasminogen-activator and normal thyroid cell adhesion to the extracellular matrix.
    Ragno P; Montuori N; Salzano S; Rossi G
    Biochimie; 1999 Apr; 81(4):355-8. PubMed ID: 10401669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin.
    Podor TJ; Peterson CB; Lawrence DA; Stefansson S; Shaughnessy SG; Foulon DM; Butcher M; Weitz JI
    J Biol Chem; 2000 Jun; 275(26):19788-94. PubMed ID: 10764803
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.
    Sharp AM; Stein PE; Pannu NS; Carrell RW; Berkenpas MB; Ginsburg D; Lawrence DA; Read RJ
    Structure; 1999 Feb; 7(2):111-8. PubMed ID: 10368279
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.
    Nip J; Rabbani SA; Shibata HR; Brodt P
    J Clin Invest; 1995 May; 95(5):2096-103. PubMed ID: 7537755
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
    Liu D; Zhou D; Wang B; Knabe WE; Meroueh SO
    ACS Chem Biol; 2015 Jun; 10(6):1521-34. PubMed ID: 25671694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Localization of urokinase type plasminogen activator to focal adhesions requires ligation of vitronectin integrin receptors.
    Wilcox-Adelman SA; Wilkins-Port CE; McKeown-Longo PJ
    Cell Adhes Commun; 2000; 7(6):477-90. PubMed ID: 11051458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.